Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Kurth

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Aging Clinical and Experimental Research|August 19, 2019
Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Adolfo Diez-Perez, Maria Luisa Brandi, Nasser Al-Daghri, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2015
Dilemmas in Managing Pregnant Women With Ebola: 2 Case ReportsSéverine Caluwaerts, Tessy Fautsch, Daphne Lagrou, et al.
BMJ (Clinical Research Ed.)|May 2, 2023
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trialsMina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, et al.
Plos One|May 11, 2011
Pan-European distribution of white-nose syndrome fungus (Geomyces destructans) not associated with mass mortalitySébastien J Puechmaille, Gudrun Wibbelt, Vanessa Korn, et al.
Aging Clinical and Experimental Research|November 4, 2022
Novel formulations of oral bisphosphonates in the treatment of osteoporosisNicholas Fuggle, Nasser Al-Daghri, Olivier Bock, et al.
Nature Reviews. Rheumatology|March 15, 2024
Evidence-Based Guideline for the management of osteoporosis in menNicholas R Fuggle, Charlotte Beaudart, Olivier Bruyère, et al.
Journal of Bone Oncology|July 29, 2025
Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOGPeyman Hadji, Matty Aapro, Nasser Al-Dagri, et al.
Nature|January 29, 2025
Bat genomes illuminate adaptations to viral tolerance and disease resistanceAriadna E Morales, Yue Dong, Thomas Brown, et al.
Nature Reviews. Rheumatology|August 11, 2025
Parathyroid hormone receptor agonists in the management of osteoporosisNicholas Fuggle, René Rizzoli, Charlotte Beaudart, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Aging Clinical and Experimental Research|August 19, 2019
Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Adolfo Diez-Perez, Maria Luisa Brandi, Nasser Al-Daghri, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2015
Dilemmas in Managing Pregnant Women With Ebola: 2 Case ReportsSéverine Caluwaerts, Tessy Fautsch, Daphne Lagrou, et al.
BMJ (Clinical Research Ed.)|May 2, 2023
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trialsMina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, et al.
Plos One|May 11, 2011
Pan-European distribution of white-nose syndrome fungus (Geomyces destructans) not associated with mass mortalitySébastien J Puechmaille, Gudrun Wibbelt, Vanessa Korn, et al.
Aging Clinical and Experimental Research|November 4, 2022
Novel formulations of oral bisphosphonates in the treatment of osteoporosisNicholas Fuggle, Nasser Al-Daghri, Olivier Bock, et al.
Nature Reviews. Rheumatology|March 15, 2024
Evidence-Based Guideline for the management of osteoporosis in menNicholas R Fuggle, Charlotte Beaudart, Olivier Bruyère, et al.
Journal of Bone Oncology|July 29, 2025
Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOGPeyman Hadji, Matty Aapro, Nasser Al-Dagri, et al.
Nature|January 29, 2025
Bat genomes illuminate adaptations to viral tolerance and disease resistanceAriadna E Morales, Yue Dong, Thomas Brown, et al.
Nature Reviews. Rheumatology|August 11, 2025
Parathyroid hormone receptor agonists in the management of osteoporosisNicholas Fuggle, René Rizzoli, Charlotte Beaudart, et al.
Pageof 10